/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. With a market cap of $53.34 billion, Edwards Lifesciences stands as a pivotal player in the medical technology industry, dedicated to improving and extending patients' lives. Competing with other prominent firms in the medical technology sector, Edwards Lifesciences' main rivals include Medtronic plc (MDT), which is known for its extensive range of innovative medical therapies and solutions.
Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Edwards Lifesciences fits this criterion perfectly, signifying its substantial size, stability, and influence in the medical technology industry. The company's global presence and expertise make it a trusted partner for healthcare providers and patients seeking advanced cardiovascular disease solutions.
